Literature DB >> 772154

Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene.

S R Webb, R M Loria, G E Madge, S Kibrick.   

Abstract

A positive correlation was found between genetic predisposition to diabetes in the mouse and susceptibility to group B Coxsackie virus in this host. Male mice of the inbred strain C57BL/Ks and the following genetic variants were used; mice homozygous for the autosomal recessive gene for diabetes (db/db), the phenotypically normal heterozygous (db/+), and the normal mice which lacked the diabetic gene (+/+). The mortality response of the +/+ mice to intraperitoneal inoculation with Coxsackie virus B4 differed from the response of the two genetic variants (db/db and db/+) derived from this strain. The db/+ variant was more susceptible to Coxsackie virus B4 than the parental background strain (+/+). The db/db variant was more susceptible than either of the other genotypes. Pathological findings of the pancreas of the three genotypes during the acute stage of infection closely paralleled the genotypically dependent susceptibility of the host.

Entities:  

Mesh:

Year:  1976        PMID: 772154      PMCID: PMC2190198          DOI: 10.1084/jem.143.5.1239

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent.

Authors:  S KIBRICK; K BENIRSCHKE
Journal:  Pediatrics       Date:  1958-11       Impact factor: 7.124

Review 2.  The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus.

Authors:  J E Craighead
Journal:  Prog Med Virol       Date:  1975

3.  The development of diabetes following Coxsackie B virus infection in mice.

Authors:  T J Coleman; K W Taylor; D R Gamble
Journal:  Diabetologia       Date:  1974-12       Impact factor: 10.122

4.  Peroral infection with group B coxsackievirus in the adult mouse: protective functions of the gut.

Authors:  R M Loria; S Kibrick; S A Broitman
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

5.  Seasonal incidence of diabetes mellitus.

Authors:  D R Gamble; K W Taylor
Journal:  Br Med J       Date:  1969-09-13

6.  Viral antibodies in diabetes mellitus.

Authors:  D R Gamble; M L Kinsley; M G FitzGerald; R Bolton; K W Taylor
Journal:  Br Med J       Date:  1969-09-13

7.  Diabetes, a new mutation in the mouse.

Authors:  K P Hummel; M M Dickie; D L Coleman
Journal:  Science       Date:  1966-09-02       Impact factor: 47.728

8.  Fuchsinophile granules in the tissues of mice infected with the Connecticut-5 strain of Coxsackie virus.

Authors:  A M PAPPENHEIMER
Journal:  J Exp Med       Date:  1952-03       Impact factor: 14.307

9.  Virus-induced diabetes mellitus. I. Hyperglycemia and hypoinsulinemia in mice infected with encephalomyocarditis virus.

Authors:  D W Boucher; A L Notkins
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

10.  Adaptation of Group B Coxsackie virus to adult mouse pancreas.

Authors:  G DALLDORF; R GIFFORD
Journal:  J Exp Med       Date:  1952-11       Impact factor: 14.307

View more
  28 in total

1.  Impaired wound healing predisposes obese mice to severe influenza virus infection.

Authors:  Kevin B O'Brien; Peter Vogel; Susu Duan; Elena A Govorkova; Richard J Webby; Jonathan A McCullers; Stacey Schultz-Cherry
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice.

Authors:  M T Barger; J E Craighead
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds.

Authors:  J Barbosa; R King; H Noreen; E J Yunis
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  Coxsackie B4 viral infection, anti-islet immunity and immunogenetics in insulin-dependent diabetes mellitus.

Authors:  G Schernthaner; H Ludwig; W R Mayr
Journal:  Acta Diabetol Lat       Date:  1978 May-Aug

5.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Inhibition of host resistance by nutritional hypercholesteremia.

Authors:  W L Kos; R M Loria; M J Snodgrass; D Cohen; T G Thorpe; A M Kaplan
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon.

Authors:  M S Horwitz; T Krahl; C Fine; J Lee; N Sarvetnick
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Influence of diabetes mellitus heredity on susceptibility to coxsackievirus B4.

Authors:  R M Loria; L B Montgomery; L A Corey; V M Chinchilli
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

9.  WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

Authors:  D M See; J G Tilles
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays.

Authors:  G Fernandes; B S Handwerger; E J Yunis; D M Brown
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.